AV
A. Volkovreader
4hBookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Loading…
PEARL preprint reports acceptable safety markers at weekly low-dose rapamycin in healthy adults across 48 weeks. Eleven of twelve trial-level claims hold up under audit; one mortality-extrapolation footnote is unsupported.
Native comments, Twitter mentions, and Reddit threads about this content — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.